Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prioritising at-risk adults in vaccine coadministration trials.
Barrella Harboe Z, Rezahosseini O, Eberhardt CS. Barrella Harboe Z, et al. Among authors: eberhardt cs. Lancet Infect Dis. 2024 Nov 25:S1473-3099(24)00674-1. doi: 10.1016/S1473-3099(24)00674-1. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39608387 No abstract available.
[Vaccination updates for the elderly].
Malézieux-Picard A, Buvelot H, Royston L, Eberhardt CS, Prendki V. Malézieux-Picard A, et al. Among authors: eberhardt cs. Rev Med Suisse. 2024 Apr 10;20(869):744-747. doi: 10.53738/REVMED.2024.20.869.744. Rev Med Suisse. 2024. PMID: 38616685 French.
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19.
Thiriard A, Meyer B, Eberhardt CS, Loevy N, Grazioli S, Adouan W, Fontannaz P, Marechal F, L'Huillier AG, Siegrist CA, Georges D, Putignano A, Marchant A, Didierlaurent AM, Blanchard-Rohner G. Thiriard A, et al. Among authors: eberhardt cs. Front Immunol. 2023 Mar 15;14:1107156. doi: 10.3389/fimmu.2023.1107156. eCollection 2023. Front Immunol. 2023. PMID: 37006315 Free PMC article.
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.
Durier C, Ninove L, Lefebvre M, Radenne A, Desaint C, Ropers J, Bauer R, Lebbah S, Carette D, Lachatre M, Lecompte AS, Deplanque D, Botelho-Nevers E, Conrad A, Dussol B, Maakaroun-Vermesse Z, Melica G, Nicolas JF, Verdon R, Kiladjian J, Loubet P, Schmidt-Mutter C, Dualé C, Ansart S, Priet S, Levier A, Molino D, Vieillard LV, Parfait B, Lelièvre JD, Tartour E, de Lamballerie X, Launay O; ANRS0002S CoviCompareP Group; AP-HP CoviCompareM Group; Biological resource centers; Laboratories; Trial coordination; Sponsor; Scientific Committee. Durier C, et al. Sci Rep. 2022 Nov 27;12(1):20373. doi: 10.1038/s41598-022-24409-w. Sci Rep. 2022. PMID: 36437298 Free PMC article.
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients.
Pradier A, Mamez AC, Stephan C, Giannotti F, Masouridi-Levrat S, Wang S, Morin S, Neofytos D, Vu DL, Melotti A, Arm I, Eberhardt CS, Tamburini J, Kaiser L, Chalandon Y, Simonetta F. Pradier A, et al. Among authors: eberhardt cs. Ann Oncol. 2022 Dec;33(12):1333-1335. doi: 10.1016/j.annonc.2022.09.153. Epub 2022 Sep 16. Ann Oncol. 2022. PMID: 36116692 Free PMC article. No abstract available.
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.
Marjot T, Eberhardt CS, Boettler T, Belli LS, Berenguer M, Buti M, Jalan R, Mondelli MU, Moreau R, Shouval D, Berg T, Cornberg M. Marjot T, et al. Among authors: eberhardt cs. J Hepatol. 2022 Oct;77(4):1161-1197. doi: 10.1016/j.jhep.2022.07.008. Epub 2022 Jul 20. J Hepatol. 2022. PMID: 35868584 Free PMC article.
60 results